BackNLS Pharmaceutics Overview

NLS Pharmaceutics Cost of Revenue

Cost of Revenue analysis for NLSP.

Quarterly Cost of Revenue

$1986.00
↓ 65.18% YoY

As of Jun 30, 2025

Annual Cost of Revenue (TTM)

$11011.00
↓ 50.26% YoY

Trailing 12 months ending Jun 30, 2025

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin